TW001

Treeway B.V. · Phase 2 active Small molecule

At a glance

Generic name	TW001
Also known as	Edaravone
Sponsor	Treeway B.V.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

ASURE: Alzheimer Study Using oRal Edaravone (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TW001 CI brief — competitive landscape report
TW001 updates RSS · CI watch RSS
Treeway B.V. portfolio CI